2
Know Who Is Viral or Bacterial This Respiratory Season FebriDx ® : Reduces GP workload Prevents spread of infection Faciltates remote testing Detects viral ARIs including COVID-19 and flu Limits unnecessary antibiotics FebriDx ® is the first and only rapid point-of-care test to differentiate a viral from bacterial acute respiratory infection (ARI) including COVID-19. Know how to manage your patients RAPID, SIMPLE, ACCURATE, AND COST-EFFECTIVE! Differentiate viral from bacterial ARIs 1-2 Rapidly isolate viral patients 3-4 Ensure patients with bacterial infections are not missed Rule out non-clinically significant infections FebriDx

Know Who Is Viral or Bacterial This Respiratory Season · 2020. 12. 23. · Know Who Is Viral or Bacterial This Respiratory Season FebriDx ®: •educes GP workloadR • Prevents

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

  • Know Who Is Viral or Bacterial This Respiratory Season

    FebriDx®:• Reduces GP workload

    • Prevents spread of infection

    • Faciltates remote testing

    • Detects viral ARIs includingCOVID-19 and flu

    • Limits unnecessary antibiotics

    FebriDx® is the first and only rapid point-of-care test to differentiate a viral from bacterial acute respiratory infection (ARI) including COVID-19.

    Know how to manage your patients

    RAPID, SIMPLE, ACCURATE, AND COST-EFFECTIVE!

    • Differentiate viral from bacterial ARIs1-2

    • Rapidly isolate viral patients3-4

    • Ensure patients with bacterial infectionsare not missed

    • Rule out non-clinically significant infections

    FebriDx

  • 1. Shapiro NI, Self WH, Rosen J, et al. A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever. Ann Med. 2018;18:1-10.

    2. Self WH, Rosen J, Sharp SC, et al. Diagnostic accuracy of FebriDx: A rapid test to detect immune responses to viral and bacterial upper respiratory infections. J Clin Med. 2017;6(10):E94.3. Karim N, Ashraf MZ, Naseem M, et al. Utility of the FebriDx point-of-care test for rapid triage and identification of possible coronavirus disease 2019 (COVID-19). Int J Clin Pract. 2020. In press.4. Clark TW, Brendish NJ, Poole S, et al. Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19. J Infect. 2020;Epub ahead of print.

    doi: 10.1016/j.jinf.2020.06.051PM-065.2 DEC 2020

    FebriDx.com • [email protected]

    FebriDx® is not currently available in the United States.

    FebriDx® is authorized to identify and differentiate viral from bacterial acute respiratory infection; its use for the specific

    diagnosis of COVID-19 is not authorized by Health Canada.

    Simple All-in-one Test. Instrument Free

    Deliver blood sampleCollect blood sample1 32 4 Deliver buffer solutionLance finger

    Prevent Spread of Infection

    PRESUMPTIVE COVID-19 PATIENTS

    SUSPECTED COVID-19 PATIENTS

    NON-COVID-19 PATIENTS

    TRIAGE WITH

    FebriDx®

    TRY FEBRIDX® IN YOUR PRACTICE AND SEE THE BENEFITS. WE WILL TRAIN YOUR STAFF, ASSIST WITH WORKFLOW, AND PROVIDE PATIENT EDUCATION TOOLS.

    8 PATIENTS SOLELY MANAGED BY HEALTHCARE PROFESSIONAL

    2 PATIENTS SEEN BY DOCTOR

    PATIENTS DISCHARGED

    10 PATIENTS WITH ARI

    10 FebriDx®PATHWAY

    Optimal Patient Management

    BACTERIALINFECTION

    VIRALINFECTION

    NON-INFECTION

    Patient with acute respiratory infection (e.g., fever, cough, shortness of breath)

    FebriDx® Rapid Triage Test

    Cohort away from patients

    with viral infections

    NON-INFECTION

    Cohort viral patients to prevent

    spread of infection and manage appropriately

    10 min.

    Save Time and Money With a FebriDx® Workflow